Home›Stock Screener›Biofil Chemicals

Biofil Chemicals Share Price Today | Stock Price & Biofil Chemicals Share Screener

BIOFILCHEM Pharmaceuticals
Live Share Price NSE
₹29.64
▲ 0.33 (1.13%)
2026-10-05 00:00:00
Live Share Price BSE
₹29.57
▼ -0.07 (-0.24%)
2026-10-05 00:00:00

As of October 5, 2026, the live Biofil Chemicals share price (NSE: BIOFILCHEM) is ₹29.64 on NSE and ₹29.57 on BSE, up 1.13% from the previous close, with shares trading between ₹29.17 and ₹30.94 in today's trading session, and a 52-week range of ₹25.79–₹46.34. Check BIOFILCHEM 52-week performance for the annual price range and momentum. Use the Biofil Chemicals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Biofil Chemicals opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹35 and net income of ₹1, with EBITDA of ₹1, an operating margin of 5.0% and a profit margin of 2.9%.

Biofil Chemicals Market Cap ₹47.70 Cr.
BIOFILCHEM P/E Ratio (TTM) 101.03
Biofil Chemicals P/B Ratio 2.29
EPS (TTM) ₹1.71
Dividend Yield -
Debt to Equity 0.09
BIOFILCHEM 52 Week High ₹46.34
Biofil Chemicals 52 Week Low ₹25.79
Operating Margin 5.00%
Profit Margin 2.86%
BIOFILCHEM Revenue (TTM) ₹35.00
EBITDA ₹1.00
Net Income ₹1.00
Total Assets ₹43.00
Total Equity ₹22.00

Biofil Chemicals Share Price Chart

Track the current stock price of Biofil Chemicals with an interactive chart. Analyse BIOFILCHEM share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Biofil Chemicals stock quote in one place.

The quote of ₹29.64 sits between the 52-week low of ₹25.79 and the 52-week high of ₹46.34, and the latest session moved 1.13% from the previous close.

Biofil Chemicals Company Profile - Fundamental Screener

Screen Biofil Chemicals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BIOFILCHEM shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE829A01014.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE829A01014

Biofil Chemicals Balance Sheet Screener

Screen BIOFILCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹43, down from ₹51 in 2025.

Latest statistics put total assets at ₹43 and shareholder funds at ₹22, with a leverage ratio of 0.09.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 43 51 47 31 19 33 42 24 24 22
Current Assets 36 43 38 22 9 24 32 14 15 13
Fixed Assets 7 8 9 9 9 10 10 10 9 9

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 22 19 18 17 17 16 15 14 13 13
Share Capital 16 16 16 16 16 16 16 16 16 16
Reserves & Surplus 5 3 2 1 1 0 -1 -3 -3 -4

Biofil Chemicals Income Statement Screener - Profit & Revenue Analysis

Screen Biofil Chemicals income statement and profit fundamentals. Analyze BIOFILCHEM quarterly results. Biofil Chemicals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹35 and net profit was ₹1, equal to earnings per unit of ₹0.30, at an operating margin of 5%.

In that period expenses were ₹34, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹32 and net profit of ₹3.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 35 32 34 41 30 23 37 30 23 13 14 14 6
Expenses 34 28 33 39 29 21 34 28 22 11 11 12 5

Operating Costs and Margins

EBITDA 1 4 1 1 1 2 2 2 1 1 3 1 1
Operating Profit % 5.00% 2.00% 3.00% 2.00% 4.00% 6.00% 4.00% 6.00% 4.00% 8.00% 19.00% 7.00% 13.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 1 3 1 1 1 1 2 2 1 1 2 1 1
Tax 0 1 0 0 0 0 1 0 0 0 1 0 0
Net Profit 1 3 1 1 1 1 1 1 1 1 2 1 1
EPS 0.30 1.71 0.34 0.44 0.34 0.44 0.77 0.74 0.30 0.29 1.10 0.48 0.36

Biofil Chemicals Cash Flow Screener - Liquidity Fundamentals

Screen BIOFILCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹1, and net cash flow was an inflow of ₹3.

Over the same period, investing activities provided ₹1 and financing activities provided ₹3.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -1 -2 2 0 0 1 1 1 1 1
Investing Activities 1 0 0 0 0 0 0 -1 0 -1

Financing and Net Cash

Financing Activities 3 0 0 0 0 -1 -1 0 0 0
Net Cash Flow 3 -2 2 0 0 0 0 0 0 0

Biofil Chemicals Shareholding Pattern Screener

See Biofil Chemicals shareholding pattern with promoter, FII, and DII holdings. Check Biofil Chemicals promoter holding and ownership changes for BIOFILCHEM on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 46.79%, foreign institutions 0.00%, domestic institutions 0.08% and the public 38.40%, spread across 25,356 shareholders.

The shareholder count was 25,356 in 2026-Mar, compared with 24,999 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 46.79% 46.79% 46.82% 46.82% 46.79% 46.79% 46.82% 46.82%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.03% 0.00%
DII Holding 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08% 0.08%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 38.40% 38.63% 38.31% 38.18% 38.23% 38.27% 38.03% 37.27%
Other Holding 14.73% 14.49% 14.79% 14.92% 14.89% 14.86% 15.04% 15.83%
Shareholder Count 25,356 24,999 25,914 25,685 25,196 24,825 26,581 25,480

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Biofil Chemicals. Biofil Chemicals dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Biofil Chemicals.

Biofil Chemicals Stock Index Membership - Nifty & Sensex

See which indices include Biofil Chemicals stock. Check BIOFILCHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Biofil Chemicals is not part of any tracked indices.
Only major market indices are tracked in our system.

Biofil Chemicals Market Events Screener - Corporate Actions

Get Biofil Chemicals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Biofil Chemicals stock events that may affect BIOFILCHEM share price, along with derivatives, futures and options activity and sector gainers.

11 corporate actions are listed, the most recent entry being Annual General Meeting dated September 23, 2026, with a record date of September 23, 2026.

It is followed by Quarterly Result Announcement dated August 11, 2026 and Quarterly Result Announcement dated May 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-23 2026-09-23 Annual General Meeting NA -2.12%
2026-08-11 2026-08-11 Quarterly Result Announcement NA 3.45%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 10.76%
2026-02-13 2026-02-13 Quarterly Result Announcement NA -10.98%
2025-11-13 2025-11-13 Quarterly Result Announcement NA 3.78%
2025-09-27 2025-09-27 Annual General Meeting NA -3.51%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -0.89%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 9.64%
2025-02-11 2025-02-11 Quarterly Result Announcement NA -2.62%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -9.36%
2024-09-30 2024-09-30 Annual General Meeting NA 23.96%

Biofil Chemicals Competitors Screener - Peer Stocks Comparison

Screen BIOFILCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 432,120 36.04 61,674 12.69% 11,565 36.68
Divis Laboratories 245,532 84.24 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 181,333 84.71 13,886 20.34% 2,138 41.12
Zydus Life Science 114,284 25.27 27,658 17.64% 5,026 47.64
Cipla 108,576 32.50 29,045 2.24% 3,870 34.78
Laurus Labs 107,198 98.20 6,868 22.01% 890 58.70
Mankind Pharma 104,707 50.04 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,679 32.41 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,479 25.84 34,145 5.56% 3,503 50.30
Lupin 92,885 16.82 29,039 26.75% 5,356 31.59

Biofil Chemicals Company Announcements - News & Reports Screener

Screen BIOFILCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 26, 2026.

The next most recent announcements are dated September 26, 2026 and September 26, 2026.

Date Update Actions
2026-09-26 Closure of Trading Window -
2026-09-26 Announcement under Regulation 30 (LODR)-Change in Management -
2026-09-26 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-23 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-28 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-26 Information Regarding E-Voting For 41St Annual General Meeting -
2026-08-26 Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants -
2026-08-26 Reg. 34 (1) Annual Report. -
2026-08-26 Submission Of Notice Of Convening 41St AGM Of The Company. -
2026-08-19 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-12 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-11 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-11 Un-Audited Financial Results For The Quarter Ended 30Th June 2026 -
2026-08-11 Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 11Th August 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-08-01 Board Meeting Intimation for Meeting Of Board Of The Directors (Serial No. 02/2026-27) Of The Company Scheduled To Be Held On Tuesday 11Th August 2026. -
2026-07-01 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-25 Closure of Trading Window -
2026-06-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-30 Audited Financial Result For The Financial Year Ended 31.03.2026 -
2026-05-30 Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 30Th May 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹29.64, within a 52-week range of ₹25.79 to ₹46.34. The P/E ratio is 101.03 and the P/B ratio is 2.29, with earnings per unit of ₹1.71. Market capitalisation stands at ₹47.70 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.